Ontology type: schema:ScholarlyArticle Open Access: True
2016-12
AUTHORSElizabeth I. Buchbinder, Anasuya Gunturi, Jessica Perritt, Janice Dutcher, Sandra Aung, Howard L. Kaufman, Marc S. Ernstoff, Girald P. Miletello, Brendan D. Curti, Gregory A. Daniels, Sapna P. Patel, John M. Kirkwood, Sigrun Hallmeyer, Joseph I. Clark, Rene Gonzalez, John M. Richart, Joe Lutzky, Michael A. Morse, Ryan J. Sullivan, David F. McDermott
ABSTRACTBACKGROUND: High dose interleukin-2 (HD IL-2) can induce durable responses in a subset of patients leading to long-term survival. Immune checkpoint blockade (ICB) has demonstrated similarly durable responses in a larger proportion of patients. However, not all patients respond to immune checkpoint blockade and subsequent therapeutic options need to be explored. METHODS: The PROCLAIM database was queried for patients with metastatic melanoma who had received HD IL-2 after treatment with ipilimumab or without prior ICB. Patient characteristics, toxicity and efficacy were analyzed. RESULTS: A total of 52 metastatic melanoma patients were treated with high dose IL-2 after ipilimumab and 276 patients were treated with high dose IL-2 without prior ICB. The overall response rate in the prior ipilimumab group was 21 % as compared to 12 % in the group that had not received prior ipilimumab. The median overall survival, measured from the initiation of HD IL-2 therapy, was 19.3 months in the prior ipilimumab group and 19.4 months in the no prior ICB group. Toxicities observed on HD IL-2 were relatively equivalent between the groups although there were cases of CTLA4 antibody-induced colitis reported after HD IL-2 treatment and a CTLA4 antibody-induced colitis related death. CONCLUSION: In this retrospective analysis HD IL-2 therapy displayed antitumor activity in melanoma patients who progressed following treatment with ipilimumab. Most HD IL-2 toxicity was not worsened by prior ipilimumab therapy except for one treatment related death from colitis. Care should be taken to avoid reactivation of CTLA4 antibody-induced colitis. More... »
PAGES52
http://scigraph.springernature.com/pub.10.1186/s40425-016-0155-8
DOIhttp://dx.doi.org/10.1186/s40425-016-0155-8
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1053272676
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/27660706
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Dana\u2013Farber Cancer Institute",
"id": "https://www.grid.ac/institutes/grid.65499.37",
"name": [
"Dana Farber Cancer Institute, Boston, MA, USA"
],
"type": "Organization"
},
"familyName": "Buchbinder",
"givenName": "Elizabeth I.",
"id": "sg:person.01054005663.52",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01054005663.52"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Lowell General Hospital",
"id": "https://www.grid.ac/institutes/grid.461527.3",
"name": [
"The Cancer Center \u2013 Lowell General Hospital, 01854, Lowell, MA, USA"
],
"type": "Organization"
},
"familyName": "Gunturi",
"givenName": "Anasuya",
"id": "sg:person.01217161672.84",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01217161672.84"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Prometheus Labs, 9410 Carroll Park Drive, 92121, San Diego, CA, USA"
],
"type": "Organization"
},
"familyName": "Perritt",
"givenName": "Jessica",
"id": "sg:person.011011237055.94",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011011237055.94"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Cancer Research Foundation of New York, Chappaqua, NY, USA"
],
"type": "Organization"
},
"familyName": "Dutcher",
"givenName": "Janice",
"id": "sg:person.0760406720.36",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0760406720.36"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Prometheus Labs, 9410 Carroll Park Drive, 92121, San Diego, CA, USA"
],
"type": "Organization"
},
"familyName": "Aung",
"givenName": "Sandra",
"id": "sg:person.01021446352.21",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021446352.21"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Rutgers University",
"id": "https://www.grid.ac/institutes/grid.430387.b",
"name": [
"Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA"
],
"type": "Organization"
},
"familyName": "Kaufman",
"givenName": "Howard L.",
"id": "sg:person.01333264012.85",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333264012.85"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Cleveland Clinic",
"id": "https://www.grid.ac/institutes/grid.239578.2",
"name": [
"Cleveland Clinic, Cleveland, OH, USA"
],
"type": "Organization"
},
"familyName": "Ernstoff",
"givenName": "Marc S.",
"id": "sg:person.01115160302.45",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01115160302.45"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Hematology\\Oncology Clinic",
"id": "https://www.grid.ac/institutes/grid.490187.3",
"name": [
"Hematology/Oncology clinic, Baton Rouge, LA, USA"
],
"type": "Organization"
},
"familyName": "Miletello",
"givenName": "Girald P.",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Providence Health & Services",
"id": "https://www.grid.ac/institutes/grid.415286.c",
"name": [
"Providence Health & Services, Portland, OR, USA"
],
"type": "Organization"
},
"familyName": "Curti",
"givenName": "Brendan D.",
"id": "sg:person.01155143760.43",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01155143760.43"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "University of California, San Diego",
"id": "https://www.grid.ac/institutes/grid.266100.3",
"name": [
"Moores UCSD Cancer Center, La Jolla, CA, USA"
],
"type": "Organization"
},
"familyName": "Daniels",
"givenName": "Gregory A.",
"id": "sg:person.01204312116.53",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204312116.53"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "The University of Texas MD Anderson Cancer Center",
"id": "https://www.grid.ac/institutes/grid.240145.6",
"name": [
"The University of Texas MD Anderson Cancer Center, 77030, Houston, TX, USA"
],
"type": "Organization"
},
"familyName": "Patel",
"givenName": "Sapna P.",
"id": "sg:person.014634030547.08",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014634030547.08"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "University of Pittsburgh",
"id": "https://www.grid.ac/institutes/grid.21925.3d",
"name": [
"University of Pittsburgh School of Medicine, Pittsburgh, PA, USA"
],
"type": "Organization"
},
"familyName": "Kirkwood",
"givenName": "John M.",
"id": "sg:person.01274445211.76",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01274445211.76"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Oncology Specialists",
"id": "https://www.grid.ac/institutes/grid.477670.5",
"name": [
"Oncology Specialists, SC, Park Ridge, IL, USA"
],
"type": "Organization"
},
"familyName": "Hallmeyer",
"givenName": "Sigrun",
"id": "sg:person.01201372106.08",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01201372106.08"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Loyola Medicine",
"id": "https://www.grid.ac/institutes/grid.470420.5",
"name": [
"Loyola Medicine, Maywood, IL, USA"
],
"type": "Organization"
},
"familyName": "Clark",
"givenName": "Joseph I.",
"id": "sg:person.0767326173.93",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0767326173.93"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "University of Colorado Anschutz Medical Campus",
"id": "https://www.grid.ac/institutes/grid.430503.1",
"name": [
"University of Colorado, Aurora, CO, USA"
],
"type": "Organization"
},
"familyName": "Gonzalez",
"givenName": "Rene",
"id": "sg:person.016205604122.71",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016205604122.71"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Saint Louis University",
"id": "https://www.grid.ac/institutes/grid.262962.b",
"name": [
"Saint Louis University, 63110, Saint Louis, MO, USA"
],
"type": "Organization"
},
"familyName": "Richart",
"givenName": "John M.",
"id": "sg:person.01152205304.09",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152205304.09"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Mount Sinai Medical Center",
"id": "https://www.grid.ac/institutes/grid.410396.9",
"name": [
"Mount Sinai Medical Center, Miami Beach, FL, USA"
],
"type": "Organization"
},
"familyName": "Lutzky",
"givenName": "Joe",
"type": "Person"
},
{
"affiliation": {
"name": [
"Duke, Durham, NC, USA"
],
"type": "Organization"
},
"familyName": "Morse",
"givenName": "Michael A.",
"id": "sg:person.013700705377.06",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013700705377.06"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Massachusetts General Hospital",
"id": "https://www.grid.ac/institutes/grid.32224.35",
"name": [
"Massachusetts General Hospital, Boston, MA, USA"
],
"type": "Organization"
},
"familyName": "Sullivan",
"givenName": "Ryan J.",
"id": "sg:person.0743410042.57",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743410042.57"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Beth Israel Deaconess Medical Center",
"id": "https://www.grid.ac/institutes/grid.239395.7",
"name": [
"Beth Israel Deaconess Medical Center, Boston, MA, USA"
],
"type": "Organization"
},
"familyName": "McDermott",
"givenName": "David F.",
"id": "sg:person.0656541200.82",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656541200.82"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1186/1479-5876-9-204",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1002969174",
"https://doi.org/10.1186/1479-5876-9-204"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmoa1414428",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1007696832"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00262-011-1172-6",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1009295521",
"https://doi.org/10.1007/s00262-011-1172-6"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.clindermatol.2012.08.006",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1009310597"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/s0140-6736(14)60958-2",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1012632588"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/(sici)1097-0142(19980815)83:4<797::aid-cncr25>3.0.co;2-m",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1015678740"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmoa1406498",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1020435459"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmoa1504030",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1024843336"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1245/aso.2005.03.536",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1024972195",
"https://doi.org/10.1245/aso.2005.03.536"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1245/aso.2005.03.536",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1024972195",
"https://doi.org/10.1245/aso.2005.03.536"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1097/01.cji.0000211334.06762.89",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1044142325"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1097/01.cji.0000211334.06762.89",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1044142325"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2013.53.0105",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1047895673"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1056/nejmoa1003466",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1052212829"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.1999.17.7.2105",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1074549817"
],
"type": "CreativeWork"
}
],
"datePublished": "2016-12",
"datePublishedReg": "2016-12-01",
"description": "BACKGROUND: High dose interleukin-2 (HD IL-2) can induce durable responses in a subset of patients leading to long-term survival. Immune checkpoint blockade (ICB) has demonstrated similarly durable responses in a larger proportion of patients. However, not all patients respond to immune checkpoint blockade and subsequent therapeutic options need to be explored.\nMETHODS: The PROCLAIM database was queried for patients with metastatic melanoma who had received HD IL-2 after treatment with ipilimumab or without prior ICB. Patient characteristics, toxicity and efficacy were analyzed.\nRESULTS: A total of 52 metastatic melanoma patients were treated with high dose IL-2 after ipilimumab and 276 patients were treated with high dose IL-2 without prior ICB. The overall response rate in the prior ipilimumab group was 21\u00a0% as compared to 12\u00a0% in the group that had not received prior ipilimumab. The median overall survival, measured from the initiation of HD IL-2 therapy, was 19.3\u00a0months in the prior ipilimumab group and 19.4\u00a0months in the no prior ICB group. Toxicities observed on HD IL-2 were relatively equivalent between the groups although there were cases of CTLA4 antibody-induced colitis reported after HD IL-2 treatment and a CTLA4 antibody-induced colitis related death.\nCONCLUSION: In this retrospective analysis HD IL-2 therapy displayed antitumor activity in melanoma patients who progressed following treatment with ipilimumab. Most HD IL-2 toxicity was not worsened by prior ipilimumab therapy except for one treatment related death from colitis. Care should be taken to avoid reactivation of CTLA4 antibody-induced colitis.",
"genre": "research_article",
"id": "sg:pub.10.1186/s40425-016-0155-8",
"inLanguage": [
"en"
],
"isAccessibleForFree": true,
"isFundedItemOf": [
{
"id": "sg:grant.2440219",
"type": "MonetaryGrant"
}
],
"isPartOf": [
{
"id": "sg:journal.1049249",
"issn": [
"2051-1426"
],
"name": "Journal for ImmunoTherapy of Cancer",
"type": "Periodical"
},
{
"issueNumber": "1",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "4"
}
],
"name": "A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma",
"pagination": "52",
"productId": [
{
"name": "readcube_id",
"type": "PropertyValue",
"value": [
"fdbfdd89b0bbe9299b656823af91dfcfe1e7c3a73f89a59a1856fc796b4f8539"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"27660706"
]
},
{
"name": "nlm_unique_id",
"type": "PropertyValue",
"value": [
"101620585"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1186/s40425-016-0155-8"
]
},
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1053272676"
]
}
],
"sameAs": [
"https://doi.org/10.1186/s40425-016-0155-8",
"https://app.dimensions.ai/details/publication/pub.1053272676"
],
"sdDataset": "articles",
"sdDatePublished": "2019-04-11T12:39",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000363_0000000363/records_70046_00000002.jsonl",
"type": "ScholarlyArticle",
"url": "https://link.springer.com/10.1186%2Fs40425-016-0155-8"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s40425-016-0155-8'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s40425-016-0155-8'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s40425-016-0155-8'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s40425-016-0155-8'
This table displays all metadata directly associated to this object as RDF triples.
296 TRIPLES
21 PREDICATES
42 URIs
21 LITERALS
9 BLANK NODES